Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under GMP conditions

Kayleigh Thirlwell, David Colligan, Joanne C Mountford, Kay Samuel, Laura Bailey, Nerea Cuesta-Gomez, Kay Hewit, Christopher Kelly, Christopher C West, Neil McGowan, John Casey, Gerard Graham, Marc Turner, Shareen Forbes, John Campbell

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalCytotherapy
Early online date20 Aug 2020
DOIs
Publication statusE-pub ahead of print - 20 Aug 2020

Cite this